This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Rothman MT (2005) Drug insight: bleeding after percutaneous coronary intervention-risks, measures and impact of anticoagulant treatment options. Nat Clin Pract Cardiovasc Med 2: 465–474
Kinnaird T et al. (2003) Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous interventions. Am J Cardiol 92: 930–935
Agostoni P et al. (2004) Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures. Systematic overview and meta-analysis of randomized trials. J Am Coll Cardiol 44: 349–356
Yusuf S et al. (2006) Comparison of Fondaparinux and Enoxaparin in Acute Coronary Syndromes. Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators. N Engl J Med 354: 1464–1476
Montalescot G (2005) STEEPLE: Safety and Efficacy of Ecnoxaparin in Percutaneous Coronary Interventin Patients, an International Randomised Evaluation. Presented at the European Society of Cardiology Congress: 2005, September 3–7; Stockholm, Sweden
Direct thrombin Inhibitor Trialists' Collaborative Group (2002) Direct Thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data. Lancet 359: 294–302
Lincoff AM et al. (2003) Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention. REPLACE-2 randomized trial. JAMA 289: 853–863
Stone GW (2006) Prospective, randomized comparison of heparin plus IIb/IIIa inhibition and bivalirudin with or without IIb/IIIa inhibition in patients with acute coronary syndromes: the ACUITY Trial. Presented at the American College of Cardiology Annual Scientific Session: 2006, March 11–14; Atlanta
Cohen DJ et al. (2004) Economic evaluation of bivalirudin with provisional glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for percutaneous coronary intervention: results from the REPLACE-2 trial. J Am Coll Cardiol 44: 1792–1800
Nikolsky E et al. (2004) Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis. J Am Coll Cardiol 44: 1200–1209
Kiemeneij F et al. (1997) Outpatient coronary stent implantation. J Am Coll Cardiol 29: 323–327
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Hamon, M. Vascular access site complications after PCI: current status and future directions. Nat Rev Cardiol 3, 402–403 (2006). https://doi.org/10.1038/ncpcardio0607
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpcardio0607